Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_assertion type Assertion NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_head.
- NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_assertion description "[According to a recent report, overexpression of the transcript variant EVI1_1d was associated with shortened survival in acute myeloid leukemia (AML), but overexpression of MDS1/EVI1, whose protein product differs structurally and functionally from that of all other known EVI1 5'-end variants, was not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_provenance.
- NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_assertion evidence source_evidence_literature NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_provenance.
- NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_assertion SIO_000772 18181178 NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_provenance.
- NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_assertion wasDerivedFrom befree-20140225 NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_provenance.
- NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_assertion wasGeneratedBy ECO_0000203 NP184941.RASZPsqUPEfxng65xSuZwXJSzJGTrnDNG0_xKvwRsaBz0130_provenance.